HIV & young people — your health, your rules, your future.

If you are somewhere between 13 and 24 and you are reading this because you are worried about HIV — worried you were exposed, worried about a test result, worried about who might find out — the most important thing to know first is that you have more control over this than you have probably been told. Not total control. But real, specific, legally backed control over who gets tested, who gets treated, and in most cases who finds out.

That matters because young people carry a share of the U.S. HIV epidemic that is wildly out of proportion to how much attention they get. In 2024, there were 38,793 HIV diagnoses among people aged 13 and older in the United States and six dependent areas, and 6,872 of them — about one in five — were among people aged 13 to 24.1 Meanwhile, only about 6% of high school students have ever been tested for HIV.5 And roughly 44% of adolescents and young adults living with HIV do not yet know they have it.4

Those three facts together describe the actual problem. It is not that young people are careless. It is that the systems built to test and treat people were designed around adults with their own insurance, their own transportation, their own mailing address, and no one else opening their mail. This page is about the workarounds — the consent laws, the privacy rules, the clinics, the medications, and the crisis lines that exist specifically so that being young does not have to mean being stuck.

The numbers — who HIV is actually reaching

Start with what federal surveillance shows, because the pattern is specific and it is not random.

Of the 6,872 HIV diagnoses among people aged 13 to 24 in 2024, the counts by age band were 23 among 13- to 14-year-olds, 320 among 15- to 17-year-olds, 1,026 among 18- to 19-year-olds, 2,929 among 20- to 22-year-olds, and 2,574 among 23- to 24-year-olds.1 The curve climbs steeply in the late teens and peaks in the early twenties — which is exactly the window in which most people are also aging out of pediatric care, leaving home, changing insurance, and losing whatever adult was previously scheduling their appointments.

Race, geography, and gender

Among those 6,872 young people, 3,291 (about 48%) were Black or African American and 2,392 (about 35%) were Hispanic or Latino, compared with 797 who were white.1 Together, Black and Latino young people accounted for roughly five out of every six diagnoses in this age group. That is not a statement about behavior. It is a statement about which communities have been under-resourced for testing, prevention, and treatment access for four decades.

Geographically, 3,892 of the 6,872 — about 57% — were in the South.1 By comparison, the West accounted for 1,046, the Midwest 949, and the Northeast 936. The southern concentration tracks closely with lower rates of Medicaid expansion, thinner public transit, fewer youth-serving HIV clinics, and school health curricula that often do not mention HIV prevention at all.

By sex, 6,015 of the diagnoses were among males and 857 among females.1 Among young men, the overwhelming majority of diagnoses were attributed to male-to-male sexual contact. Among young women, most were attributed to heterosexual contact, with 78 attributed to injection drug use.1

One important limitation: federal surveillance tables report counts by sex as recorded, not by gender identity, which means transgender and nonbinary young people are largely invisible in the headline numbers.1 If you are a trans young person trying to find yourself in the data, the honest answer is that the data mostly does not look for you. That is a measurement failure, not evidence that you are not affected.

Young people already living with HIV

At the end of 2024, 27,406 people aged 13 to 24 were living with diagnosed HIV in the United States and six dependent areas — 22,343 male and 5,063 female.1 Of those, 3,341 acquired HIV perinatally, meaning around the time of birth.1 That last group deserves specific mention: several thousand young Americans have been living with HIV literally their whole lives, have been taking medication since before they could read, and are now navigating adulthood, dating, and disclosure with a diagnosis they never got to react to as news.

The good news, and the gap

Estimated new HIV infections among people aged 13 to 24 fell by about 30% between 2018 and 2022.3 That is one of the sharpest declines in any age group, and it is real progress driven by testing, treatment as prevention, and PrEP.

The gap is on the care side. In 2024, 83.1% of people newly diagnosed nationally were linked to HIV care within one month — but among people aged 13 to 24, linkage was 82.0%, the lowest of any age group.2 At the same time, young people aged 13 to 24 had the highest proportion of diagnoses at stage 0, at 11.2% — meaning very recent infection caught early, often through repeat testing.2 And about 34% of adolescents and young adults with diagnosed HIV are not virally suppressed.4

Read those together and the story is clear: young people are getting diagnosed earlier than anyone, and then falling through the floor on the way to treatment. The rest of this page is about the specific reasons that happens, and what actually fixes them.

Minor consent — what you can do without a parent

This is the single most misunderstood thing in youth HIV care, including by some clinic staff.

As of July 2026, all 50 states and the District of Columbia allow minors to consent to STI testing and treatment — which includes HIV — without parental consent.7 There is no state where a minor is flatly barred from getting an HIV test on their own.

The eight states with age floors

Eight states set a minimum age rather than allowing any minor to consent. Alabama, California, Delaware, and Illinois set the floor at 12; New Jersey sets it at 13 specifically for HIV; and Hawaii, Idaho, and North Dakota set it at 14.7 Idaho is a genuine tangle: a 2024 provision of Idaho Code (§ 32-1015) requires parental consent for health care provided to minors, and there is not yet case law resolving how that interacts with the state's existing law letting 14-year-olds consent to STI services.7 If you are a young person in Idaho, ask the clinic directly how they are handling it before you give your name.

The sixteen states where a provider may tell your parents

Consenting on your own and staying private are two different questions. Sixteen states have parental notification provisions attached to minors' STI services: Alabama, Arkansas, Delaware, Georgia, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Missouri, Montana, New Jersey, and Oregon.7 In most of these, notification is permitted rather than required — the provider may tell a parent, and many choose not to.

Three states are more specific. In Iowa, a provider is required to inform a minor's legal guardians of a positive HIV test result. In Massachusetts, notification is required if the minor's life or limb is endangered. In New Jersey, a provider must notify a parent if the minor has experienced sexual assault, unless doing so is not in the minor's best interest.7

Florida is not on that list. In Florida, a minor may consent, and the state has no parental notification provisions for STI services.7

Florida Statute 384.30, in plain language

Florida's law is unusually clear, and worth knowing by name. Section 384.30 says the Department of Health, licensed physicians, licensed nurses, and any public or private hospital, clinic, or health facility "may examine and provide treatment for sexually transmissible diseases to any minor," and that "the consent of the parents or guardians of a minor is not a prerequisite for an examination or treatment."8

Subsection (2) is the part almost nobody knows about, and it is the strongest privacy language in this whole article: the fact of consultation, examination, and treatment of a minor for a sexually transmissible disease is confidential, exempt from public records disclosure, and "shall not be divulged in any direct or indirect manner, such as sending a bill for services rendered to a parent or guardian."8

Read that again. Florida law names the billing statement specifically as a prohibited form of disclosure. If you are a minor in Florida and a clinic tells you a bill has to go to your parents, they are describing their billing software, not the law.

What about PrEP, not just testing?

Prevention is a slightly different legal question from treatment, because some consent statutes are written around diagnosis and treatment of an existing infection. CDC's review found that no state explicitly prohibits a minor from consenting on their own to PrEP, and that all states have statutes or regulations explicitly allowing certain minors to consent to STI diagnosis and treatment.10 Seven states explicitly cover both HIV and prevention in their minor-consent laws, and nine more broadly allow minors to consent to any health care service, which arguably includes PrEP.10 In the remaining states, minors may still be able to consent through case law or a broad reading of "treatment" — which is exactly why the answer often depends on the individual clinic's legal counsel.10

CDC's current clinical guidance tells providers to consult local law, to explicitly discuss confidentiality with adolescent patients up front, and — in its own words — that if the law permits, providers should allow adolescent patients who would benefit from PrEP to decide for themselves whether to take it.11

The Explanation of Benefits problem

Here is the failure mode that undoes more young people's privacy than any consent law: the envelope.

If you are covered as a dependent on a parent's health insurance, the plan generates an Explanation of Benefits — an EOB — after a claim. It is not a bill, but it lists the date, the provider, and often a code or plain-English description of the service. It goes to the policyholder. CDC named this problem directly: billing documentation from commercial health insurance companies in an Explanation of Benefits "provides a potential mechanism of disclosure of services provided to adolescents covered under their parents' or guardians' health insurance."10

So you can legally consent to an HIV test at 15, walk out with a negative result and a PrEP prescription, and be outed three weeks later by a piece of paper on the kitchen counter. That is not a hypothetical; it is the single most common reason young people give for not using insurance for sexual health care at all.

The federal tool: a confidential communications request

HIPAA includes a specific, enforceable right most people have never heard of. Under 45 CFR § 164.522(b), a covered health care provider "must permit individuals to request and must accommodate reasonable requests" to receive communications of protected health information "by alternative means or at alternative locations."9 A provider may not require you to explain why you are asking.9

Health plans have a slightly different standard: a plan must accommodate reasonable requests to send communications by alternative means or to an alternative location "if the individual clearly states that the disclosure of all or part of that information could endanger the individual."9 The plan may require the request in writing, may require that endangerment statement, may ask you to specify the alternative address or contact method, and may ask how payment will be handled.9

In practice that means the request needs three things: a specific alternative address, phone number, or email; a clear statement that disclosure at the usual address could endanger you; and it should be in writing. Call the member services number on the insurance card and ask for the "confidential communications request" form.

The same regulation contains a second lever. Providers must permit you to request restrictions on uses and disclosures for treatment, payment, and health care operations, and there is a specific provision covering restriction of disclosure to a health plan where the service has been paid for in full out of pocket.9 Translated: if you pay cash for a visit, you can ask that it never be sent to the insurance company at all — which means no claim, and therefore no EOB.

One more practical note: insurance disruption is not just a privacy problem, it is an adherence problem. In a study of young men who have sex with men aged 16 to 29, the most commonly reported reasons for stopping PrEP included difficulty getting to appointments, a lapse in insurance coverage, and a sense of no longer needing it.10 If your coverage is about to change, raise it with your clinic before it happens, not after.

Getting tested — the confidential routes

CDC recommends that everyone between 13 and 64 be tested for HIV at least once, and that people with ongoing risk factors test at least annually.22 Given that only about 6% of high school students report ever having been tested — and that reported condom use among high school students fell from 60% in 2011 to 52% in 2021 — that once-in-a-lifetime baseline is not being met.5

You have more options than a doctor's office.

Free HIV self-tests mailed to you

Together TakeMeHome is a federal partnership with a stated goal of distributing at least one million free HIV self-tests over five years. It is supported by CDC, Emory University, Building Healthy Online Communities, the National Alliance of State and Territorial AIDS Directors, Signal Group, and OraSure Technologies, and it expands on an earlier program that distributed 100,000 free self-tests in eight months.17 Orders are placed at takemehome.org, which advertises free kits shipped in a discreet package and maintains a published privacy section.

An oral-swab self-test gives you a result at home in about 20 minutes, with no clinic, no insurance claim, and no one else in the room. That is often the single most useful first step for a young person who is not sure who they can trust yet.

The limits of self-tests, honestly

Two caveats matter. First, self-tests are less sensitive than laboratory tests at detecting very recent infection, and for that reason CDC says HIV self-tests are usually not recommended for people who are taking PrEP, though clinicians may consider them when other options are not available.17 Second, a reactive self-test result is a signal to get confirmatory laboratory testing, not a final answer.

A middle option exists: home specimen collection kits are mailed to you, contain supplies to collect a fingerstick blood sample or self-collected swab, are mailed back to a laboratory, and are sensitive enough to detect recent infection — with results returned through a clinician.17

In-person options that tend to be youth-friendly

• County or state health department clinics. Usually free, usually no insurance claim, and staffed by people who read the minor consent statute for a living.
• Ryan White–funded programs. More than half of all people diagnosed with HIV in the United States — over 600,000 people — receive services through the Ryan White HIV/AIDS Program each year.16
• School-based health centers. Where they exist and where state law permits, they remove the transportation barrier entirely.
• LGBTQ+ community health centers. Generally the most practiced at confidential adolescent care and at not making anything weird.

If you are in Florida, the state HIV/AIDS Hotline is 1-800-352-2437 in English, 1-800-545-7432 in Spanish, and 1-800-243-7101 in Haitian Creole, with 1-888-503-7118 for hearing and speech impaired callers; you can also text FLHIV to 898211.22

PrEP when you are under 18

PrEP — pre-exposure prophylaxis — is HIV medication taken by someone who does not have HIV, to prevent acquiring it. There are now four FDA-approved options in the United States, and the age and weight rules on them have changed enough recently that a lot of well-meaning clinicians are working from outdated information.

The four options and who they are labeled for

CDC lists emtricitabine/tenofovir disoproxil fumarate (F/TDF, brand name Truvada or a generic), emtricitabine/tenofovir alafenamide (F/TAF, brand name Descovy), and cabotegravir extended-release injectable suspension (CAB, brand name Apretude), and states that these medications are approved to prevent HIV in adults and adolescents weighing at least 77 pounds (35 kilograms).11 Daily oral F/TDF is recommended for anyone with sexual or injection risk factors; daily oral F/TAF is recommended for sexual transmission but excludes people likely to acquire HIV through receptive vaginal sex, because it has not been studied in that population.11

Apretude's FDA prescribing information states it is indicated for PrEP in adults and adolescents weighing at least 35 kg. It is given as an injection, with a second dose one month later and then every two months.11 The adolescent indication is supported by open-label trials — HPTN 083-01 and HPTN 084-01 — that enrolled 64 adolescents aged 12 to under 18 weighing at least 35 kg; 62 received at least one injection, the safety profile was comparable to adults, and no HIV infections occurred among them.12 Safety and effectiveness have not been established in children under 12.12

The newest option is lenacapavir (brand name Yeztugo), approved on June 18, 2025 and indicated for PrEP in adults and adolescents weighing at least 35 kg. After initiation dosing, it is given as a 927 mg subcutaneous injection every 26 weeks — twice a year.13 In September 2025, CDC issued a formal recommendation strongly recommending lenacapavir injections every six months as PrEP for people weighing at least 77 pounds (35 kg), citing efficacy of 100% among females and 96% in a primarily male study population over 52 weeks.14

Bones, and why it comes up

The most-studied safety question in adolescent PrEP is bone mineral density with tenofovir disoproxil fumarate. Data have shown bone density changes in young gay and bisexual men during PrEP use and after a 48-week trial period, and while declines reversed in adults, they persisted in younger men.11 Because F/TAF appears to have less bone effect than F/TDF, CDC suggests considering F/TAF for adolescent male patients starting PrEP.11

The underlying trials are worth knowing by name, because they are the reason adolescent PrEP exists at all. ATN 113 was an open-label study in U.S. adolescents aged 15 to 17; ATN 110 covered ages 18 to 22; and ATN 117 examined vitamin D status and tenofovir exposure in relation to bone toxicity.10 Overall, the available data support the safety of PrEP in adolescents, and routine DXA bone scans are not recommended for people taking PrEP.10

The part nobody says out loud: taking it is the hard part

The ATN studies found something that has shaped adolescent PrEP care ever since. Adherence declined when clinic visits moved from monthly to quarterly — in both the younger ATN 113 participants and the older ATN 110 participants — even though participants received structured, client-centered adherence counseling.10 CDC's guidance draws the obvious conclusion: adolescents prescribed PrEP may benefit from more frequent, supportive interactions.11

Practical translation: if you are starting PrEP, ask for monthly check-ins rather than quarterly, even if the clinic offers quarterly by default. Ask about text reminders, peer navigators, flexible or after-hours appointments, and whether they can do refills without a full visit.10 None of that is asking for special treatment; it is the evidence-based version of the service.

Two other notes. On-demand "2-1-1" dosing exists for some people who have sex infrequently, but CDC specifically says it should not be prescribed to people who might have trouble with a complex dosing schedule, and names adolescents as an example.11 And if your clinician wants prescribing advice, the National Clinician Consultation Center PrEPline is at 1-855-448-7737, Monday through Friday.11

A positive result at 16 — what actually happens next

First, the medical sequence, so nothing is a surprise. A reactive rapid or self-test is followed by confirmatory laboratory testing. Then baseline bloodwork — viral load, CD4 count, and a resistance test — plus screening for other infections. Then antiretroviral therapy, ideally started fast, sometimes the same day.

Most people can get HIV under control within about six months of starting treatment.6 That is the whole arc. Not decades. Months.

Second, the emotional part, which is the part that actually determines what happens next. You do not have to tell anyone today. Not a parent, not a partner, not a friend, not a coach. There is no clinical clock forcing disclosure, and there is no version of this where panicking in the first 48 hours improves your outcome. What matters in the first weeks is getting into care and starting medication — which you can do while telling exactly zero people in your personal life.

Young people newly diagnosed are, statistically, the group most likely to be caught very early: 11.2% of diagnoses among 13- to 24-year-olds in 2024 were at stage 0, the highest of any age group.2 Early detection is genuinely good news for long-term health. The risk is the next step — linkage to care was 82.0% among 13- to 24-year-olds, the lowest of any age group.2 If there is one sentence to take from this page: the diagnosis is not the dangerous moment. The four weeks after it are.

Research networks built specifically for you

The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) is the only multicenter research network in the United States devoted to the health and well-being of adolescents and young adults living with or at risk for HIV, focused specifically on ages 13 through 24.15 It was started in 2001 by the NICHD Maternal and Pediatric Infectious Disease Branch and is co-funded by the National Institute on Drug Abuse and the National Institute of Mental Health.15

ATN's stated priorities read like a list of exactly the gaps described on this page: undiagnosed HIV among youth, persistent new acquisitions, care engagement, antiretroviral adherence and viral suppression, and adverse outcomes.15 The current cycle launched in 2023 and is organized around a Scientific Leadership Center and an Operations and Collaborations Center; specific current sites are not listed publicly on the network's overview page, so the practical move is to ask your HIV clinic whether they participate in or refer to ATN studies.15 Being in a study is not a last resort — for young people it often means more frequent contact, more support, and more people whose job is to keep you in care.

Where youth-specific HIV care lives

The Ryan White HIV/AIDS Program is the reason most people in the U.S. can get HIV care regardless of income, and it has a part written specifically for young people.

The program has five parts. Part A funds Eligible Metropolitan Areas and Transitional Grant Areas. Part B funds states and territories, including the AIDS Drug Assistance Program. Part C funds community-based outpatient ambulatory care. Part F funds AIDS Education and Training Centers, Special Projects of National Significance, dental programs, and the Minority AIDS Initiative.16

Part D is the one to ask for by name. It provides grants to local community-based organizations and funds medical care for low-income women, infants, children, and youth living with HIV, plus support services for them and their family members.16 That family-inclusive design is the point: a Part D program is built on the assumption that a young person's care involves transportation, food, housing instability, guardianship questions, and siblings — not just a prescription.

What youth-friendly care actually looks like

When you are calling clinics, these are the things worth asking about, because they are the things that predict whether you stay in care:

• Do you see patients under 18 without parental consent, and what gets mailed home?
• Is there a case manager or peer navigator assigned to me, with a phone number I can text?
• Can appointments happen after school, or by telehealth?
• Is behavioral health in the same building, or do I have to go somewhere else?
• Do you help with transportation, food, or housing referrals?
• Are you a Ryan White Part C or Part D program, and can you cover my medications if my insurance falls apart?

If a clinic answers yes to most of that, take the appointment even if it is farther away. Continuity beats convenience.

School, college, and who has to know

Almost nobody. That is the short version.

Your HIV status is health information. Schools, universities, roommates, teammates, coaches, and professors have no automatic entitlement to it. There is no academic form that requires it, no dorm policy that requires it, and no sport that requires it. Disclosure to a roommate is never required — it is a choice you make when and if you decide the relationship warrants it.

What matters practically at school is logistics and privacy plumbing:

Medication logistics

Antiretroviral therapy is once-daily for most people, which is far easier to manage in a dorm than in a household with a locked medicine cabinet and a curious sibling. Think about a 90-day mail-order supply shipped to a campus address, a pill organizer that does not announce itself, a phone alarm rather than a labeled bottle on a desk, and a plan for breaks and travel. If you are also on a parent's insurance, the mail-order pharmacy address is one more thing a confidential communications request can redirect.9

Campus health and student insurance

College health centers can usually prescribe and manage PrEP and often HIV care, or refer you. The catch is the same one from earlier: if you are billing a parent's plan, the EOB goes to the policyholder, and CDC has flagged that mechanism explicitly.10 A student health plan in your own name, a confidential communications request, or a Ryan White–funded clinic off campus each solve it in a different way.916

If you are transferring care to a college town

Do this before the semester starts, not after you run out of medication. Get a copy of your labs, the name of your regimen, your case manager's contact, and a written referral. Ask your current clinic to make the introduction directly — a warm handoff from one clinician to another is the single most reliable way to avoid a gap, and gaps are where viral rebound happens.

Turning 18 — the most dangerous handoff in HIV care

If you grew up in pediatric or adolescent HIV care, the transition to adult care is the point where the system most often loses people. The reasons are structural, and they stack.

The clinic changes. The people who have known you since you were seven are replaced by an adult ID clinic with a different rhythm, less hand-holding, and a waiting room full of strangers. Insurance changes — at 18, at graduation, at 26, at any job change. Guardianship changes, meaning nobody is scheduling your appointments anymore. And the frequency of contact usually drops, right at the moment the evidence says it should not: adherence declined in the ATN studies specifically when visits moved from monthly to quarterly.10

Layer that on top of the fact that 13- to 24-year-olds already have the lowest linkage-to-care rate of any age group,2 and about a third of adolescents and young adults with diagnosed HIV are not virally suppressed,4 and transition looks less like a milestone and more like a cliff.

A transition checklist that actually holds

• Start 12 to 18 months early. Transition is a process, not an appointment.
• Ask your Part C or Part D program what transition support they offer. Part D is funded to serve youth and their families, which makes it the natural place to raise this.16
• Learn your own regimen. Drug names, doses, allergies, last viral load, last CD4. If you have been on medication since childhood, you may never have been asked to know this.
• Get your own portal login, your own pharmacy account, and your own phone number on file.
• Meet the adult clinician once while you are still in pediatric care. A joint visit converts a stranger into a known quantity.
• Map the insurance cliff. Know the date, and know what ADAP through Ryan White Part B covers if coverage lapses.16
• Front-load contact after the switch. Ask for monthly touchpoints for the first six months, then step down.10

Mental health, crisis support, and substance use

A new HIV diagnosis in your teens or early twenties arrives on top of everything else that age already involves. Anxiety, depression, isolation, and fear of disclosure are ordinary responses, not weakness, and they are also the strongest practical predictors of whether someone stays in care and takes medication consistently.

If you need someone right now

The 988 Suicide & Crisis Lifeline is reachable by calling or texting 988 from anywhere in the United States.19

For LGBTQ+ young people specifically, The Trevor Project provides crisis counseling by text, chat, or phone, 24 hours a day, 365 days a year, from anywhere in the U.S. It states plainly that the service is confidential and 100% free, that counselors are trained in the challenges LGBTQ+ young people face, and that you can share as much or as little as you want.18 It is also honest about limits: in very specific instances of abuse or a clear concern of an in-progress or imminent suicide, counselors may need to contact a child welfare agency or emergency service.18 Knowing that boundary in advance is better than discovering it mid-conversation.

Substance use, without the lecture

Substance use and HIV intersect in young people's lives constantly, and the useful response is practical rather than moral. CDC's clinical guidance directs providers to link patients to syringe services programs where they are legal and available, to prescribe syringes, and to advise patients that syringes can be purchased at pharmacies without a prescription where local law allows.11 Federal guidance also directs providers to screen for barriers such as unstable housing and to offer resources, referrals, or counseling.10

Nothing you say about substance use should cost you your HIV care. If it does, that is a signal about the clinic, not about you — and adolescent-focused and Ryan White programs are generally the most practiced at having that conversation without flinching.16

Ask for integrated care

When you are choosing a clinic, ask whether behavioral health is in the same building and on the same chart. Co-located care means one trip, one intake, one set of people who already know your situation — which for a young person without a car is often the difference between getting therapy and not.

Sex, dating, and disclosure — the version that is actually true

Here is the fact that changes the entire emotional weight of an HIV diagnosis, and that a lot of young people are never told directly: if you have an undetectable viral load, you will not transmit HIV through sex. That is CDC's own language, and it is what "Undetectable = Untransmittable" — U=U — means.6

Most people can get their viral load under control within six months of starting treatment.6 An undetectable viral load also prevents transmission through pregnancy, labor, and delivery, and it likely reduces the risk of transmission through shared injection equipment, though by how much is not known.6

So the honest framing for a 19-year-old is not "you have to be careful forever." It is: take your medication, get to undetectable, stay there, and sex is not a transmission risk. That is a reasonable thing to build a life and a relationship on.

Disclosure to partners

Disclosure is a decision with legal, emotional, and safety dimensions that vary by state, and it is worth reading about in depth rather than improvising. A few things are broadly true: you get to choose the timing; you get to choose the setting; the first conversation does not have to be the whole conversation; and rehearsing it once out loud, with a counselor or a peer navigator, makes it go dramatically better. If a partner does not have HIV, they can also start PrEP — which turns a scary asymmetry into a shared, boring, manageable routine.11

Apps, photos, and practical safety

Dating apps are how a large share of young people meet partners, and the risks that actually materialize are usually not medical. They are location exposure, screenshots, and coercion. Practical habits: turn off precise-distance features; keep your face out of photos you would not want reposted; do not put your status, your school, or your workplace in a profile you would not want a relative to find; meet in public first; tell one friend where you are going. If someone threatens to out you, that is coercion — not a negotiation you have to participate in.

On nudes: assume anything sent can be saved. That is not a moral position, it is a technical one. And if you are under 18, sharing sexual images of a minor — including yourself — carries legal exposure that varies by state and is worth understanding before it becomes urgent.

Trans and nonbinary youth — HIV care in a shifting legal landscape

For trans young people, HIV care and gender-affirming care are not separate errands. They are usually the same clinic, the same clinician, and the same fragile relationship of trust — which means policy that disrupts one disrupts the other.

As of its August 14, 2026 update, KFF's tracker counts 27 states that have enacted laws or policies limiting youth access to gender-affirming care, with about half of transgender youth aged 13 to 17 living in a state that has enacted such a law. Twenty-five bans remain in place, with bans in Montana and Arkansas blocked by court order, and 24 states impose professional or legal penalties on health care practitioners who provide gender-affirming care to minors.20

On August 11, 2026, the Centers for Medicare and Medicaid Services issued a final rule prohibiting federal Medicaid or CHIP funds from covering puberty blockers, hormone therapy, and surgery for enrollees under 18 in Medicaid and under 19 in CHIP. It is not a blanket ban — it expressly permits states to use state-only funds — and it does not prohibit coverage of counseling or psychotherapy as part of gender-affirming care. It includes a tapering period of up to six months for enrollees already receiving hormone therapy as of the effective date, 60 days after publication; the tapering provision does not apply to puberty blockers. KFF estimates about 130,000 young trans people with Medicaid or CHIP coverage live in states without existing restrictions and could face new limitations.21

Why this shows up in HIV outcomes

The mechanism is not complicated. When the clinic that provided hormones stops providing them — or closes, or the clinician leaves the state — the young person often stops going. HIV testing, PrEP refills, ART refills, and behavioral health were bundled into that same visit. Losing one service in a bundle tends to cost you the whole bundle.

Practical hedges, none of them ideal, all of them better than nothing:

• Separate your HIV care from your gender-affirming care, on purpose. Establish with a Ryan White–funded HIV provider independently, so that HIV medication and monitoring continue no matter what happens to the other service.16
• Get ahead of refills. Ask for the longest supply your pharmacy and plan allow, and know your ADAP options through Ryan White Part B if coverage changes.16
• Keep your own records. Copies of labs, prescriptions, and clinic letters travel with you; institutional records sometimes do not.
• Know that PrEP eligibility is weight-based, not gender-based. The FDA labels for both Apretude and Yeztugo are written for adults and adolescents weighing at least 35 kg.1213
• Use crisis support that is built for you. The Trevor Project is free, confidential, and available 24/7 by text, chat, or phone.18

Florida specifics

Florida is one of the most consequential states in the country for young people and HIV, in both directions — a heavy epidemic, and unusually protective minor-consent language.

The epidemic

In 2023, Florida recorded 4,725 new HIV diagnoses. Of those, 139 (2%) were among people aged 13 to 19 and 1,285 (27%) were among people aged 20 to 29 — meaning more than a quarter of the state's new diagnoses were in the twenties alone.22 At the end of 2023, 128,497 people with HIV were living in Florida, a rate of 566.4 per 100,000, with about one in 177 adults living with HIV statewide — and one in 64 Black Floridians.22

Florida ranked third among states for HIV diagnosis rate based on 2022 diagnoses, at 19.3 per 100,000 against a national rate of 11.3.22 The Miami–Fort Lauderdale–West Palm Beach metro had the highest HIV diagnosis rate of any U.S. metropolitan statistical area in 2022, at 30.8 per 100,000, with Orlando–Kissimmee–Sanford also in the top ten at 21.0.22 By county in 2023, Miami-Dade recorded 1,048 diagnoses, Broward 588, Orange 461, Hillsborough 378, Palm Beach 282, Duval 273, and Pinellas 164.22

Put next to the national finding that 57% of youth diagnoses are in the South,1 Florida is not a footnote in the youth HIV story. It is a main character.

The law, which is on your side

Guttmacher's July 2026 tracking lists Florida as a state where a minor may consent to STI services, with no parental notification provisions.7 Section 384.30, Florida Statutes, is the underlying law: parental consent "is not a prerequisite for an examination or treatment," and a minor's STI care is confidential and may not be divulged directly or indirectly, including by sending a bill to a parent or guardian.8

If you are a young person in Florida, that is a real, citable thing you can say at a front desk.

How to find care here

Start with the Florida HIV/AIDS Hotline: 1-800-352-2437 (English), 1-800-545-7432 (Spanish), 1-800-243-7101 (Haitian Creole), 1-888-503-7118 (hearing/speech impaired), or text FLHIV to 898211.22 Ask two specific questions: whether the program is Ryan White Part C or Part D funded, and whether it sees minors without parental consent. Part D programs are the ones funded specifically to serve youth and families.16 County health departments in Miami-Dade, Broward, Orange, Duval, Hillsborough, and Pinellas all sit in the highest-volume counties in the state and are the most likely to have youth-experienced staff on site.22

What to do this week

Nothing on this page requires a parent, a car, or money. Pick the ones that apply.

• If you have never been tested: order a free HIV self-test through Together TakeMeHome at takemehome.org, or call your county health department.17 CDC's baseline recommendation is at least once for everyone 13 to 64.22
• If you are worried about an ongoing risk: ask about PrEP. All four FDA-approved options are labeled for adults and adolescents weighing at least 35 kg (77 lb).111213 Ask for monthly rather than quarterly follow-up.10
• If you are worried about privacy: call your insurer and ask for a confidential communications request form, in writing, with an alternative address.9 Or use a health department or Ryan White clinic and skip the claim entirely.16
• If you were just diagnosed: book the first care appointment before you tell anyone. Linkage within one month is the metric that matters most, and it is the one young people miss most often.2
• If you are already in care: know your last viral load. Undetectable means you will not transmit HIV through sex.6
• If you are approaching 18 or moving: start the transition conversation now and ask for a warm handoff to a named adult clinician.16
• If today is heavy: call or text 988,19 or reach The Trevor Project by text, chat, or phone — free, confidential, 24/7.18